14 Aug 2025
43min 14sec
Join us for the Market Access Summit panel discussion on the evolving role of private payers in Canada’s healthcare system. This session features insights from industry leaders Bobby Currie (Manulife), Martin Chung (Equitable Life Canada), and David Greiss (Green Shield Canada). Discover how: Private insurers are adapting to healthcare system pressures The challenges of providing […]
14 Aug 2025
37min 38sec
Join leading experts Dr. Quinn Grundy (University of Toronto), Andrea Jaray (Alexion Canada), and Sandra Hanna (Neighborhood Pharmacy Association of Canada) as they dive deep into the evolution, challenges, and future of Patient Support Programs (PSPs) in Canada. The panel explores: How PSPs fill critical healthcare system gaps Learn how to support patients with complex […]
04 Aug 2025
42min 42sec
Join leading experts from Bayer, Health Canada, Arthritis Society, and Knight Therapeutics as they dive deep into the challenges of bringing innovative treatments to Canadian patients. Key highlights include: insights from regulatory, industry, and patient perspectives, challenges in Canada’s drug approval process, innovative approaches to streamline market access and more. In this panel discussion, industry […]
04 Aug 2025
25min 15sec
Industry experts from Insight Biosciences, AbbVie, GSK, and IQVIA discuss the latest PMPRB guidelines and their potential impact on drug pricing, market access, and healthcare innovation in Canada. Key Topics: – PMPRB’s evolving regulatory approach – Potential effects on drug launches and R&D investments – Strategies for pharmaceutical manufacturers – Balancing drug pricing and patient […]
14 Aug 2025
Dr. Farah Husein, Director of Science & Methods at Canada’s Drug Agency, introduces CDA-AMC’s role as a pan-Canadian health organization dedicated to improving coordination, alignment, and value in the drug and health technology system. The presentation outlines the agency’s expanded mandate following the 2023 government announcement, including three strategic pillars—Appropriate Use, Data & Analytics, and […]
04 Aug 2025
Latest Developments at INESSS At the 2024 Market Access Canada Summit, Mélanie Caron outlined major updates from INESSS, highlighting legislative changes, process improvements, and strategic priorities shaping Quebec’s drug evaluation and reimbursement landscape. Key Highlights: Bill 15 (2023): Limits hospital use to drugs with a federal Notice of Compliance for INESSS-recognized indications; mandates sharing pharmacology […]
14 Aug 2025
Dr. Kendall Jamieson Gilmore, Associate Director of Strategy at NICE, outlines how global collaboration in Health Technology Assessment can accelerate access to innovation, strengthen system readiness, and enhance patient outcomes. The presentation highlights NICE’s recent progress in delivering faster, more relevant, and impactful guidance, then explores key areas of international cooperation—horizon scanning, method alignment, and […]
Loading...
